Skip Navigation


European Heart Journal Advance Access originally published online on June 1, 2009
European Heart Journal 2009 30(13):1549-1550; doi:10.1093/eurheartj/ehp216
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/13/1549    most recent
ehp216v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Olivotto, I.
Right arrow Articles by Yacoub, M. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olivotto, I.
Right arrow Articles by Yacoub, M. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil

Iacopo Olivotto1,*, Franco Cecchi1 and Magdi H. Yacoub2

1 Referral Center for Myocardial Diseases, Heart and Vessel Department, Careggi University Hospital, Florence, Italy
2 Heart Science Centre, Imperial College London, Harefield, UK

* Corresponding author. Tel: +39 055 7945138, Fax: +39 055 7949335; Email: olivottoi@aou-careggi.toscana.it

This editorial refers to ‘Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death’{dagger}, by C. Basso et al., on page 1627

The first 10% of the full text of this article appears below.

Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease at the clinical, phenotypic, and molecular level.1 In spite of considerable progress in understanding the disease, many issues continue to be shrouded in mystery, with very slow and often incomplete shedding of the veils, reminiscent of Salome's dance. These issues include the unpredictable occurrence of sudden cardiac death, the clinical relevance of coronary artery bridging, and their possible relationship.1–6

To this day, HCM is among the most common causes of sudden cardiac death in the young, and strategies aimed at improving risk stratification remain less than satisfactory, largely due to the capricious course and individual heterogeneity of the disease.7 Several potential predictors of risk have been identified, each with very low positive predictive accuracy, that may be important in some patients but have . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death
Cristina Basso, Gaetano Thiene, Shannon Mackey-Bojack, Anna Chiara Frigo, Domenico Corrado, and Barry J. Maron
EHJ 2009 30: 1627-1634. [Abstract] [Full Text]